nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproheptadine—migraine—Prednisone—multiple sclerosis	0.782	1	CpDpCtD
Cyproheptadine—HTR2A—trigeminal nucleus—multiple sclerosis	0.0146	0.238	CbGeAlD
Cyproheptadine—HTR2A—trigeminal nerve—multiple sclerosis	0.00384	0.0625	CbGeAlD
Cyproheptadine—HTR2A—pons—multiple sclerosis	0.00271	0.044	CbGeAlD
Cyproheptadine—SLC6A2—nerve—multiple sclerosis	0.00233	0.038	CbGeAlD
Cyproheptadine—DRD2—nerve—multiple sclerosis	0.00213	0.0346	CbGeAlD
Cyproheptadine—HTR2A—pineal body—multiple sclerosis	0.00193	0.0314	CbGeAlD
Cyproheptadine—HTR2A—peripheral nervous system—multiple sclerosis	0.0018	0.0293	CbGeAlD
Cyproheptadine—HTR2A—nerve—multiple sclerosis	0.0014	0.0228	CbGeAlD
Cyproheptadine—HTR2C—brainstem—multiple sclerosis	0.0012	0.0195	CbGeAlD
Cyproheptadine—HTR6—nervous system—multiple sclerosis	0.00109	0.0177	CbGeAlD
Cyproheptadine—HTR6—central nervous system—multiple sclerosis	0.00105	0.017	CbGeAlD
Cyproheptadine—HTR1A—brainstem—multiple sclerosis	0.00101	0.0164	CbGeAlD
Cyproheptadine—SLC6A2—brainstem—multiple sclerosis	0.001	0.0163	CbGeAlD
Cyproheptadine—DRD2—brainstem—multiple sclerosis	0.000913	0.0148	CbGeAlD
Cyproheptadine—DRD2—retina—multiple sclerosis	0.000881	0.0143	CbGeAlD
Cyproheptadine—HTR2C—medulla oblongata—multiple sclerosis	0.000837	0.0136	CbGeAlD
Cyproheptadine—HTR6—brain—multiple sclerosis	0.000832	0.0135	CbGeAlD
Cyproheptadine—HTR2C—midbrain—multiple sclerosis	0.000765	0.0124	CbGeAlD
Cyproheptadine—HTR2C—spinal cord—multiple sclerosis	0.000747	0.0121	CbGeAlD
Cyproheptadine—SLC6A2—medulla oblongata—multiple sclerosis	0.000699	0.0114	CbGeAlD
Cyproheptadine—CHRM2—nervous system—multiple sclerosis	0.000653	0.0106	CbGeAlD
Cyproheptadine—HTR1A—midbrain—multiple sclerosis	0.000644	0.0105	CbGeAlD
Cyproheptadine—HTR2C—nervous system—multiple sclerosis	0.000629	0.0102	CbGeAlD
Cyproheptadine—HTR1A—spinal cord—multiple sclerosis	0.000628	0.0102	CbGeAlD
Cyproheptadine—CHRM2—central nervous system—multiple sclerosis	0.000628	0.0102	CbGeAlD
Cyproheptadine—HTR2C—central nervous system—multiple sclerosis	0.000606	0.00985	CbGeAlD
Cyproheptadine—HTR2A—brainstem—multiple sclerosis	0.000602	0.00979	CbGeAlD
Cyproheptadine—CHRM1—nervous system—multiple sclerosis	0.000594	0.00966	CbGeAlD
Cyproheptadine—HTR2B—nervous system—multiple sclerosis	0.000591	0.00961	CbGeAlD
Cyproheptadine—DRD2—midbrain—multiple sclerosis	0.000582	0.00946	CbGeAlD
Cyproheptadine—HTR2A—retina—multiple sclerosis	0.000581	0.00945	CbGeAlD
Cyproheptadine—CHRM1—central nervous system—multiple sclerosis	0.000572	0.0093	CbGeAlD
Cyproheptadine—HTR2B—central nervous system—multiple sclerosis	0.000569	0.00925	CbGeAlD
Cyproheptadine—CHRM3—nervous system—multiple sclerosis	0.000532	0.00864	CbGeAlD
Cyproheptadine—HTR1A—nervous system—multiple sclerosis	0.00053	0.00861	CbGeAlD
Cyproheptadine—SLC6A2—nervous system—multiple sclerosis	0.000525	0.00854	CbGeAlD
Cyproheptadine—CHRM3—central nervous system—multiple sclerosis	0.000512	0.00832	CbGeAlD
Cyproheptadine—HTR1A—central nervous system—multiple sclerosis	0.00051	0.00829	CbGeAlD
Cyproheptadine—SLC6A2—central nervous system—multiple sclerosis	0.000506	0.00822	CbGeAlD
Cyproheptadine—CHRM2—brain—multiple sclerosis	0.000499	0.00811	CbGeAlD
Cyproheptadine—HTR1A—cerebellum—multiple sclerosis	0.000498	0.0081	CbGeAlD
Cyproheptadine—HTR2C—brain—multiple sclerosis	0.000481	0.00782	CbGeAlD
Cyproheptadine—DRD2—nervous system—multiple sclerosis	0.000478	0.00778	CbGeAlD
Cyproheptadine—DRD2—central nervous system—multiple sclerosis	0.000461	0.00749	CbGeAlD
Cyproheptadine—CHRM1—brain—multiple sclerosis	0.000454	0.00738	CbGeAlD
Cyproheptadine—HTR2B—brain—multiple sclerosis	0.000452	0.00734	CbGeAlD
Cyproheptadine—DRD2—cerebellum—multiple sclerosis	0.00045	0.00732	CbGeAlD
Cyproheptadine—Irritability—Dexamethasone—multiple sclerosis	0.000421	0.00444	CcSEcCtD
Cyproheptadine—Irritability—Betamethasone—multiple sclerosis	0.000421	0.00444	CcSEcCtD
Cyproheptadine—HTR2A—medulla oblongata—multiple sclerosis	0.00042	0.00683	CbGeAlD
Cyproheptadine—Decreased appetite—Cladribine—multiple sclerosis	0.000418	0.00442	CcSEcCtD
Cyproheptadine—Weight increased—Prednisolone—multiple sclerosis	0.000415	0.00439	CcSEcCtD
Cyproheptadine—Fatigue—Cladribine—multiple sclerosis	0.000415	0.00438	CcSEcCtD
Cyproheptadine—Constipation—Cladribine—multiple sclerosis	0.000412	0.00435	CcSEcCtD
Cyproheptadine—Sweating increased—Triamcinolone—multiple sclerosis	0.000409	0.00432	CcSEcCtD
Cyproheptadine—Increased appetite—Prednisone—multiple sclerosis	0.000408	0.00431	CcSEcCtD
Cyproheptadine—Sweating increased—Methylprednisolone—multiple sclerosis	0.000408	0.00431	CcSEcCtD
Cyproheptadine—CHRM3—brain—multiple sclerosis	0.000406	0.00661	CbGeAlD
Cyproheptadine—HTR1A—brain—multiple sclerosis	0.000405	0.00658	CbGeAlD
Cyproheptadine—SLC6A2—brain—multiple sclerosis	0.000401	0.00652	CbGeAlD
Cyproheptadine—Chills—Mitoxantrone—multiple sclerosis	0.0004	0.00422	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Prednisolone—multiple sclerosis	0.000399	0.00421	CcSEcCtD
Cyproheptadine—Feeling abnormal—Cladribine—multiple sclerosis	0.000397	0.00419	CcSEcCtD
Cyproheptadine—HTR2A—midbrain—multiple sclerosis	0.000384	0.00624	CbGeAlD
Cyproheptadine—Thrombocytopenia—Azathioprine—multiple sclerosis	0.000383	0.00405	CcSEcCtD
Cyproheptadine—Urticaria—Cladribine—multiple sclerosis	0.000382	0.00404	CcSEcCtD
Cyproheptadine—Weight increased—Triamcinolone—multiple sclerosis	0.000382	0.00403	CcSEcCtD
Cyproheptadine—Weight increased—Methylprednisolone—multiple sclerosis	0.000381	0.00402	CcSEcCtD
Cyproheptadine—HRH1—nervous system—multiple sclerosis	0.000378	0.00614	CbGeAlD
Cyproheptadine—HTR2A—spinal cord—multiple sclerosis	0.000375	0.00609	CbGeAlD
Cyproheptadine—Sweating increased—Betamethasone—multiple sclerosis	0.000371	0.00392	CcSEcCtD
Cyproheptadine—Sweating increased—Dexamethasone—multiple sclerosis	0.000371	0.00392	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Triamcinolone—multiple sclerosis	0.000367	0.00387	CcSEcCtD
Cyproheptadine—Irritability—Prednisone—multiple sclerosis	0.000366	0.00387	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Methylprednisolone—multiple sclerosis	0.000366	0.00387	CcSEcCtD
Cyproheptadine—DRD2—brain—multiple sclerosis	0.000366	0.00595	CbGeAlD
Cyproheptadine—Hypotension—Azathioprine—multiple sclerosis	0.000366	0.00386	CcSEcCtD
Cyproheptadine—Vision blurred—Mitoxantrone—multiple sclerosis	0.000365	0.00386	CcSEcCtD
Cyproheptadine—Photosensitivity—Methotrexate—multiple sclerosis	0.000365	0.00386	CcSEcCtD
Cyproheptadine—HRH1—central nervous system—multiple sclerosis	0.000364	0.00591	CbGeAlD
Cyproheptadine—Hepatic failure—Methotrexate—multiple sclerosis	0.000357	0.00377	CcSEcCtD
Cyproheptadine—Leukopenia—Mitoxantrone—multiple sclerosis	0.000347	0.00366	CcSEcCtD
Cyproheptadine—Weight increased—Betamethasone—multiple sclerosis	0.000347	0.00366	CcSEcCtD
Cyproheptadine—Weight increased—Dexamethasone—multiple sclerosis	0.000347	0.00366	CcSEcCtD
Cyproheptadine—Asthenia—Cladribine—multiple sclerosis	0.000345	0.00365	CcSEcCtD
Cyproheptadine—Convulsion—Mitoxantrone—multiple sclerosis	0.000336	0.00355	CcSEcCtD
Cyproheptadine—Hallucination—Methylprednisolone—multiple sclerosis	0.000333	0.00352	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Betamethasone—multiple sclerosis	0.000333	0.00351	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Dexamethasone—multiple sclerosis	0.000333	0.00351	CcSEcCtD
Cyproheptadine—Diarrhoea—Cladribine—multiple sclerosis	0.000329	0.00348	CcSEcCtD
Cyproheptadine—Sweating increased—Prednisone—multiple sclerosis	0.000323	0.00341	CcSEcCtD
Cyproheptadine—Feeling abnormal—Azathioprine—multiple sclerosis	0.000322	0.00341	CcSEcCtD
Cyproheptadine—Confusional state—Mitoxantrone—multiple sclerosis	0.000319	0.00337	CcSEcCtD
Cyproheptadine—Dizziness—Cladribine—multiple sclerosis	0.000318	0.00336	CcSEcCtD
Cyproheptadine—Oedema—Mitoxantrone—multiple sclerosis	0.000316	0.00334	CcSEcCtD
Cyproheptadine—HTR2A—nervous system—multiple sclerosis	0.000316	0.00513	CbGeAlD
Cyproheptadine—Shock—Mitoxantrone—multiple sclerosis	0.000311	0.00329	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.00031	0.00327	CcSEcCtD
Cyproheptadine—Tachycardia—Mitoxantrone—multiple sclerosis	0.000309	0.00326	CcSEcCtD
Cyproheptadine—Irritability—Methotrexate—multiple sclerosis	0.000306	0.00323	CcSEcCtD
Cyproheptadine—Vomiting—Cladribine—multiple sclerosis	0.000306	0.00323	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.000306	0.00323	CcSEcCtD
Cyproheptadine—HTR2A—central nervous system—multiple sclerosis	0.000304	0.00494	CbGeAlD
Cyproheptadine—Rash—Cladribine—multiple sclerosis	0.000303	0.0032	CcSEcCtD
Cyproheptadine—Hallucination—Betamethasone—multiple sclerosis	0.000303	0.0032	CcSEcCtD
Cyproheptadine—Hallucination—Dexamethasone—multiple sclerosis	0.000303	0.0032	CcSEcCtD
Cyproheptadine—Dermatitis—Cladribine—multiple sclerosis	0.000303	0.0032	CcSEcCtD
Cyproheptadine—Weight increased—Prednisone—multiple sclerosis	0.000302	0.00319	CcSEcCtD
Cyproheptadine—Anorexia—Mitoxantrone—multiple sclerosis	0.000302	0.00318	CcSEcCtD
Cyproheptadine—Headache—Cladribine—multiple sclerosis	0.000301	0.00318	CcSEcCtD
Cyproheptadine—Vision blurred—Prednisolone—multiple sclerosis	0.0003	0.00316	CcSEcCtD
Cyproheptadine—HTR2A—cerebellum—multiple sclerosis	0.000297	0.00483	CbGeAlD
Cyproheptadine—Hypotension—Mitoxantrone—multiple sclerosis	0.000296	0.00312	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Prednisone—multiple sclerosis	0.00029	0.00306	CcSEcCtD
Cyproheptadine—HRH1—brain—multiple sclerosis	0.000289	0.0047	CbGeAlD
Cyproheptadine—Nausea—Cladribine—multiple sclerosis	0.000286	0.00302	CcSEcCtD
Cyproheptadine—Vertigo—Prednisolone—multiple sclerosis	0.000286	0.00302	CcSEcCtD
Cyproheptadine—Syncope—Prednisolone—multiple sclerosis	0.000285	0.00301	CcSEcCtD
Cyproheptadine—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000284	0.003	CcSEcCtD
Cyproheptadine—Somnolence—Mitoxantrone—multiple sclerosis	0.000281	0.00297	CcSEcCtD
Cyproheptadine—Loss of consciousness—Prednisolone—multiple sclerosis	0.000279	0.00295	CcSEcCtD
Cyproheptadine—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000278	0.00294	CcSEcCtD
Cyproheptadine—Convulsion—Prednisolone—multiple sclerosis	0.000276	0.00291	CcSEcCtD
Cyproheptadine—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000275	0.0029	CcSEcCtD
Cyproheptadine—Fatigue—Mitoxantrone—multiple sclerosis	0.000273	0.00288	CcSEcCtD
Cyproheptadine—Constipation—Mitoxantrone—multiple sclerosis	0.000271	0.00286	CcSEcCtD
Cyproheptadine—Diarrhoea—Azathioprine—multiple sclerosis	0.000268	0.00283	CcSEcCtD
Cyproheptadine—Hallucination—Prednisone—multiple sclerosis	0.000264	0.00279	CcSEcCtD
Cyproheptadine—Vertigo—Triamcinolone—multiple sclerosis	0.000263	0.00277	CcSEcCtD
Cyproheptadine—Syncope—Triamcinolone—multiple sclerosis	0.000262	0.00277	CcSEcCtD
Cyproheptadine—Vertigo—Methylprednisolone—multiple sclerosis	0.000262	0.00277	CcSEcCtD
Cyproheptadine—Syncope—Methylprednisolone—multiple sclerosis	0.000262	0.00276	CcSEcCtD
Cyproheptadine—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000261	0.00275	CcSEcCtD
Cyproheptadine—Oedema—Prednisolone—multiple sclerosis	0.00026	0.00274	CcSEcCtD
Cyproheptadine—Dizziness—Azathioprine—multiple sclerosis	0.000259	0.00273	CcSEcCtD
Cyproheptadine—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000257	0.00271	CcSEcCtD
Cyproheptadine—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000256	0.00271	CcSEcCtD
Cyproheptadine—Shock—Prednisolone—multiple sclerosis	0.000255	0.0027	CcSEcCtD
Cyproheptadine—Convulsion—Triamcinolone—multiple sclerosis	0.000253	0.00268	CcSEcCtD
Cyproheptadine—Tachycardia—Prednisolone—multiple sclerosis	0.000253	0.00267	CcSEcCtD
Cyproheptadine—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.000253	0.00267	CcSEcCtD
Cyproheptadine—Convulsion—Methylprednisolone—multiple sclerosis	0.000253	0.00267	CcSEcCtD
Cyproheptadine—Urticaria—Mitoxantrone—multiple sclerosis	0.000251	0.00265	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000251	0.00265	CcSEcCtD
Cyproheptadine—Vomiting—Azathioprine—multiple sclerosis	0.000249	0.00263	CcSEcCtD
Cyproheptadine—Drowsiness—Methotrexate—multiple sclerosis	0.000247	0.00261	CcSEcCtD
Cyproheptadine—Rash—Azathioprine—multiple sclerosis	0.000247	0.00261	CcSEcCtD
Cyproheptadine—Dermatitis—Azathioprine—multiple sclerosis	0.000246	0.0026	CcSEcCtD
Cyproheptadine—Headache—Azathioprine—multiple sclerosis	0.000245	0.00259	CcSEcCtD
Cyproheptadine—HTR2A—brain—multiple sclerosis	0.000241	0.00392	CbGeAlD
Cyproheptadine—Confusional state—Methylprednisolone—multiple sclerosis	0.00024	0.00254	CcSEcCtD
Cyproheptadine—Oedema—Triamcinolone—multiple sclerosis	0.000239	0.00252	CcSEcCtD
Cyproheptadine—Vertigo—Betamethasone—multiple sclerosis	0.000238	0.00252	CcSEcCtD
Cyproheptadine—Vertigo—Dexamethasone—multiple sclerosis	0.000238	0.00252	CcSEcCtD
Cyproheptadine—Syncope—Dexamethasone—multiple sclerosis	0.000238	0.00251	CcSEcCtD
Cyproheptadine—Syncope—Betamethasone—multiple sclerosis	0.000238	0.00251	CcSEcCtD
Cyproheptadine—Shock—Triamcinolone—multiple sclerosis	0.000235	0.00248	CcSEcCtD
Cyproheptadine—Insomnia—Prednisolone—multiple sclerosis	0.000235	0.00248	CcSEcCtD
Cyproheptadine—Shock—Methylprednisolone—multiple sclerosis	0.000234	0.00247	CcSEcCtD
Cyproheptadine—Loss of consciousness—Betamethasone—multiple sclerosis	0.000233	0.00246	CcSEcCtD
Cyproheptadine—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000233	0.00246	CcSEcCtD
Cyproheptadine—Paraesthesia—Prednisolone—multiple sclerosis	0.000233	0.00246	CcSEcCtD
Cyproheptadine—Tachycardia—Triamcinolone—multiple sclerosis	0.000233	0.00246	CcSEcCtD
Cyproheptadine—Nausea—Azathioprine—multiple sclerosis	0.000232	0.00245	CcSEcCtD
Cyproheptadine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000232	0.00245	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000231	0.00244	CcSEcCtD
Cyproheptadine—Agranulocytosis—Methotrexate—multiple sclerosis	0.000231	0.00244	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.00023	0.00243	CcSEcCtD
Cyproheptadine—Convulsion—Dexamethasone—multiple sclerosis	0.00023	0.00243	CcSEcCtD
Cyproheptadine—Convulsion—Betamethasone—multiple sclerosis	0.00023	0.00243	CcSEcCtD
Cyproheptadine—Asthenia—Mitoxantrone—multiple sclerosis	0.000227	0.0024	CcSEcCtD
Cyproheptadine—Hypotension—Methylprednisolone—multiple sclerosis	0.000223	0.00235	CcSEcCtD
Cyproheptadine—Hepatitis—Methotrexate—multiple sclerosis	0.000222	0.00234	CcSEcCtD
Cyproheptadine—Vision blurred—Prednisone—multiple sclerosis	0.000218	0.0023	CcSEcCtD
Cyproheptadine—Oedema—Betamethasone—multiple sclerosis	0.000217	0.00229	CcSEcCtD
Cyproheptadine—Oedema—Dexamethasone—multiple sclerosis	0.000217	0.00229	CcSEcCtD
Cyproheptadine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000216	0.00229	CcSEcCtD
Cyproheptadine—Insomnia—Triamcinolone—multiple sclerosis	0.000216	0.00228	CcSEcCtD
Cyproheptadine—Insomnia—Methylprednisolone—multiple sclerosis	0.000215	0.00227	CcSEcCtD
Cyproheptadine—Paraesthesia—Triamcinolone—multiple sclerosis	0.000214	0.00226	CcSEcCtD
Cyproheptadine—Feeling abnormal—Prednisolone—multiple sclerosis	0.000214	0.00226	CcSEcCtD
Cyproheptadine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000214	0.00226	CcSEcCtD
Cyproheptadine—Shock—Dexamethasone—multiple sclerosis	0.000213	0.00225	CcSEcCtD
Cyproheptadine—Shock—Betamethasone—multiple sclerosis	0.000213	0.00225	CcSEcCtD
Cyproheptadine—Agitation—Prednisone—multiple sclerosis	0.000212	0.00224	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000212	0.00224	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000212	0.00224	CcSEcCtD
Cyproheptadine—Tachycardia—Dexamethasone—multiple sclerosis	0.000211	0.00223	CcSEcCtD
Cyproheptadine—Tachycardia—Betamethasone—multiple sclerosis	0.000211	0.00223	CcSEcCtD
Cyproheptadine—Dyspepsia—Triamcinolone—multiple sclerosis	0.00021	0.00222	CcSEcCtD
Cyproheptadine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.00021	0.00221	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000209	0.00221	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000209	0.00221	CcSEcCtD
Cyproheptadine—Vertigo—Prednisone—multiple sclerosis	0.000208	0.00219	CcSEcCtD
Cyproheptadine—Syncope—Prednisone—multiple sclerosis	0.000207	0.00219	CcSEcCtD
Cyproheptadine—Tinnitus—Methotrexate—multiple sclerosis	0.000207	0.00218	CcSEcCtD
Cyproheptadine—Anorexia—Dexamethasone—multiple sclerosis	0.000206	0.00218	CcSEcCtD
Cyproheptadine—Anorexia—Betamethasone—multiple sclerosis	0.000206	0.00218	CcSEcCtD
Cyproheptadine—Urticaria—Prednisolone—multiple sclerosis	0.000206	0.00218	CcSEcCtD
Cyproheptadine—Fatigue—Triamcinolone—multiple sclerosis	0.000206	0.00217	CcSEcCtD
Cyproheptadine—Fatigue—Methylprednisolone—multiple sclerosis	0.000205	0.00217	CcSEcCtD
Cyproheptadine—Loss of consciousness—Prednisone—multiple sclerosis	0.000203	0.00214	CcSEcCtD
Cyproheptadine—Hypotension—Betamethasone—multiple sclerosis	0.000202	0.00214	CcSEcCtD
Cyproheptadine—Hypotension—Dexamethasone—multiple sclerosis	0.000202	0.00214	CcSEcCtD
Cyproheptadine—Vomiting—Mitoxantrone—multiple sclerosis	0.000201	0.00212	CcSEcCtD
Cyproheptadine—Convulsion—Prednisone—multiple sclerosis	0.0002	0.00211	CcSEcCtD
Cyproheptadine—Rash—Mitoxantrone—multiple sclerosis	0.000199	0.00211	CcSEcCtD
Cyproheptadine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000199	0.0021	CcSEcCtD
Cyproheptadine—Chills—Methotrexate—multiple sclerosis	0.000199	0.0021	CcSEcCtD
Cyproheptadine—Headache—Mitoxantrone—multiple sclerosis	0.000198	0.00209	CcSEcCtD
Cyproheptadine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000197	0.00208	CcSEcCtD
Cyproheptadine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000196	0.00207	CcSEcCtD
Cyproheptadine—Insomnia—Betamethasone—multiple sclerosis	0.000196	0.00207	CcSEcCtD
Cyproheptadine—Insomnia—Dexamethasone—multiple sclerosis	0.000196	0.00207	CcSEcCtD
Cyproheptadine—Paraesthesia—Dexamethasone—multiple sclerosis	0.000194	0.00205	CcSEcCtD
Cyproheptadine—Paraesthesia—Betamethasone—multiple sclerosis	0.000194	0.00205	CcSEcCtD
Cyproheptadine—Dyspepsia—Betamethasone—multiple sclerosis	0.000191	0.00201	CcSEcCtD
Cyproheptadine—Dyspepsia—Dexamethasone—multiple sclerosis	0.000191	0.00201	CcSEcCtD
Cyproheptadine—Urticaria—Triamcinolone—multiple sclerosis	0.00019	0.002	CcSEcCtD
Cyproheptadine—Urticaria—Methylprednisolone—multiple sclerosis	0.000189	0.002	CcSEcCtD
Cyproheptadine—Oedema—Prednisone—multiple sclerosis	0.000189	0.00199	CcSEcCtD
Cyproheptadine—Decreased appetite—Betamethasone—multiple sclerosis	0.000188	0.00199	CcSEcCtD
Cyproheptadine—Decreased appetite—Dexamethasone—multiple sclerosis	0.000188	0.00199	CcSEcCtD
Cyproheptadine—Nausea—Mitoxantrone—multiple sclerosis	0.000188	0.00198	CcSEcCtD
Cyproheptadine—Fatigue—Dexamethasone—multiple sclerosis	0.000187	0.00197	CcSEcCtD
Cyproheptadine—Fatigue—Betamethasone—multiple sclerosis	0.000187	0.00197	CcSEcCtD
Cyproheptadine—Shock—Prednisone—multiple sclerosis	0.000186	0.00196	CcSEcCtD
Cyproheptadine—Tachycardia—Prednisone—multiple sclerosis	0.000184	0.00194	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Prednisone—multiple sclerosis	0.000182	0.00193	CcSEcCtD
Cyproheptadine—Vision blurred—Methotrexate—multiple sclerosis	0.000182	0.00192	CcSEcCtD
Cyproheptadine—Anorexia—Prednisone—multiple sclerosis	0.00018	0.0019	CcSEcCtD
Cyproheptadine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000178	0.00188	CcSEcCtD
Cyproheptadine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000178	0.00188	CcSEcCtD
Cyproheptadine—Vertigo—Methotrexate—multiple sclerosis	0.000174	0.00183	CcSEcCtD
Cyproheptadine—Leukopenia—Methotrexate—multiple sclerosis	0.000173	0.00183	CcSEcCtD
Cyproheptadine—Urticaria—Dexamethasone—multiple sclerosis	0.000172	0.00182	CcSEcCtD
Cyproheptadine—Urticaria—Betamethasone—multiple sclerosis	0.000172	0.00182	CcSEcCtD
Cyproheptadine—Dizziness—Prednisolone—multiple sclerosis	0.000172	0.00181	CcSEcCtD
Cyproheptadine—Asthenia—Triamcinolone—multiple sclerosis	0.000171	0.00181	CcSEcCtD
Cyproheptadine—Asthenia—Methylprednisolone—multiple sclerosis	0.000171	0.0018	CcSEcCtD
Cyproheptadine—Insomnia—Prednisone—multiple sclerosis	0.000171	0.0018	CcSEcCtD
Cyproheptadine—Paraesthesia—Prednisone—multiple sclerosis	0.000169	0.00179	CcSEcCtD
Cyproheptadine—Convulsion—Methotrexate—multiple sclerosis	0.000167	0.00177	CcSEcCtD
Cyproheptadine—Dyspepsia—Prednisone—multiple sclerosis	0.000166	0.00175	CcSEcCtD
Cyproheptadine—Decreased appetite—Prednisone—multiple sclerosis	0.000164	0.00173	CcSEcCtD
Cyproheptadine—Rash—Prednisolone—multiple sclerosis	0.000164	0.00173	CcSEcCtD
Cyproheptadine—Dermatitis—Prednisolone—multiple sclerosis	0.000163	0.00173	CcSEcCtD
Cyproheptadine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000163	0.00172	CcSEcCtD
Cyproheptadine—Fatigue—Prednisone—multiple sclerosis	0.000163	0.00172	CcSEcCtD
Cyproheptadine—Headache—Prednisolone—multiple sclerosis	0.000163	0.00172	CcSEcCtD
Cyproheptadine—Constipation—Prednisone—multiple sclerosis	0.000161	0.0017	CcSEcCtD
Cyproheptadine—Confusional state—Methotrexate—multiple sclerosis	0.000159	0.00168	CcSEcCtD
Cyproheptadine—Dizziness—Triamcinolone—multiple sclerosis	0.000158	0.00167	CcSEcCtD
Cyproheptadine—Dizziness—Methylprednisolone—multiple sclerosis	0.000157	0.00166	CcSEcCtD
Cyproheptadine—Feeling abnormal—Prednisone—multiple sclerosis	0.000155	0.00164	CcSEcCtD
Cyproheptadine—Asthenia—Dexamethasone—multiple sclerosis	0.000155	0.00164	CcSEcCtD
Cyproheptadine—Asthenia—Betamethasone—multiple sclerosis	0.000155	0.00164	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000154	0.00163	CcSEcCtD
Cyproheptadine—Nausea—Prednisolone—multiple sclerosis	0.000154	0.00163	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000152	0.00161	CcSEcCtD
Cyproheptadine—Vomiting—Triamcinolone—multiple sclerosis	0.000152	0.0016	CcSEcCtD
Cyproheptadine—Vomiting—Methylprednisolone—multiple sclerosis	0.000151	0.0016	CcSEcCtD
Cyproheptadine—Rash—Triamcinolone—multiple sclerosis	0.00015	0.00159	CcSEcCtD
Cyproheptadine—Dermatitis—Triamcinolone—multiple sclerosis	0.00015	0.00159	CcSEcCtD
Cyproheptadine—Anorexia—Methotrexate—multiple sclerosis	0.00015	0.00159	CcSEcCtD
Cyproheptadine—Rash—Methylprednisolone—multiple sclerosis	0.00015	0.00159	CcSEcCtD
Cyproheptadine—Dermatitis—Methylprednisolone—multiple sclerosis	0.00015	0.00158	CcSEcCtD
Cyproheptadine—Urticaria—Prednisone—multiple sclerosis	0.00015	0.00158	CcSEcCtD
Cyproheptadine—Headache—Triamcinolone—multiple sclerosis	0.00015	0.00158	CcSEcCtD
Cyproheptadine—Headache—Methylprednisolone—multiple sclerosis	0.000149	0.00158	CcSEcCtD
Cyproheptadine—Diarrhoea—Betamethasone—multiple sclerosis	0.000148	0.00156	CcSEcCtD
Cyproheptadine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000148	0.00156	CcSEcCtD
Cyproheptadine—Hypotension—Methotrexate—multiple sclerosis	0.000147	0.00156	CcSEcCtD
Cyproheptadine—Dizziness—Dexamethasone—multiple sclerosis	0.000143	0.00151	CcSEcCtD
Cyproheptadine—Dizziness—Betamethasone—multiple sclerosis	0.000143	0.00151	CcSEcCtD
Cyproheptadine—Insomnia—Methotrexate—multiple sclerosis	0.000143	0.00151	CcSEcCtD
Cyproheptadine—Nausea—Triamcinolone—multiple sclerosis	0.000142	0.0015	CcSEcCtD
Cyproheptadine—Paraesthesia—Methotrexate—multiple sclerosis	0.000142	0.00149	CcSEcCtD
Cyproheptadine—Nausea—Methylprednisolone—multiple sclerosis	0.000141	0.00149	CcSEcCtD
Cyproheptadine—Somnolence—Methotrexate—multiple sclerosis	0.00014	0.00148	CcSEcCtD
Cyproheptadine—Dyspepsia—Methotrexate—multiple sclerosis	0.000139	0.00147	CcSEcCtD
Cyproheptadine—Vomiting—Dexamethasone—multiple sclerosis	0.000138	0.00145	CcSEcCtD
Cyproheptadine—Vomiting—Betamethasone—multiple sclerosis	0.000138	0.00145	CcSEcCtD
Cyproheptadine—Decreased appetite—Methotrexate—multiple sclerosis	0.000137	0.00145	CcSEcCtD
Cyproheptadine—Rash—Dexamethasone—multiple sclerosis	0.000137	0.00144	CcSEcCtD
Cyproheptadine—Rash—Betamethasone—multiple sclerosis	0.000137	0.00144	CcSEcCtD
Cyproheptadine—Dermatitis—Dexamethasone—multiple sclerosis	0.000136	0.00144	CcSEcCtD
Cyproheptadine—Dermatitis—Betamethasone—multiple sclerosis	0.000136	0.00144	CcSEcCtD
Cyproheptadine—Fatigue—Methotrexate—multiple sclerosis	0.000136	0.00143	CcSEcCtD
Cyproheptadine—Headache—Betamethasone—multiple sclerosis	0.000136	0.00143	CcSEcCtD
Cyproheptadine—Headache—Dexamethasone—multiple sclerosis	0.000136	0.00143	CcSEcCtD
Cyproheptadine—Asthenia—Prednisone—multiple sclerosis	0.000135	0.00143	CcSEcCtD
Cyproheptadine—Feeling abnormal—Methotrexate—multiple sclerosis	0.00013	0.00137	CcSEcCtD
Cyproheptadine—Diarrhoea—Prednisone—multiple sclerosis	0.000129	0.00136	CcSEcCtD
Cyproheptadine—Nausea—Betamethasone—multiple sclerosis	0.000129	0.00136	CcSEcCtD
Cyproheptadine—Nausea—Dexamethasone—multiple sclerosis	0.000129	0.00136	CcSEcCtD
Cyproheptadine—Urticaria—Methotrexate—multiple sclerosis	0.000125	0.00132	CcSEcCtD
Cyproheptadine—Dizziness—Prednisone—multiple sclerosis	0.000125	0.00132	CcSEcCtD
Cyproheptadine—Vomiting—Prednisone—multiple sclerosis	0.00012	0.00127	CcSEcCtD
Cyproheptadine—Rash—Prednisone—multiple sclerosis	0.000119	0.00126	CcSEcCtD
Cyproheptadine—Dermatitis—Prednisone—multiple sclerosis	0.000119	0.00125	CcSEcCtD
Cyproheptadine—Headache—Prednisone—multiple sclerosis	0.000118	0.00125	CcSEcCtD
Cyproheptadine—Asthenia—Methotrexate—multiple sclerosis	0.000113	0.00119	CcSEcCtD
Cyproheptadine—Nausea—Prednisone—multiple sclerosis	0.000112	0.00118	CcSEcCtD
Cyproheptadine—Diarrhoea—Methotrexate—multiple sclerosis	0.000108	0.00114	CcSEcCtD
Cyproheptadine—Dizziness—Methotrexate—multiple sclerosis	0.000104	0.0011	CcSEcCtD
Cyproheptadine—Vomiting—Methotrexate—multiple sclerosis	0.0001	0.00106	CcSEcCtD
Cyproheptadine—Rash—Methotrexate—multiple sclerosis	9.94e-05	0.00105	CcSEcCtD
Cyproheptadine—Dermatitis—Methotrexate—multiple sclerosis	9.93e-05	0.00105	CcSEcCtD
Cyproheptadine—Headache—Methotrexate—multiple sclerosis	9.87e-05	0.00104	CcSEcCtD
Cyproheptadine—Nausea—Methotrexate—multiple sclerosis	9.36e-05	0.000989	CcSEcCtD
Cyproheptadine—HTR2B—GPCR downstream signaling—IL2—multiple sclerosis	1.4e-05	0.000226	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—POMC—multiple sclerosis	1.39e-05	0.000225	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—IL2—multiple sclerosis	1.39e-05	0.000225	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CCR2—multiple sclerosis	1.39e-05	0.000224	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—POMC—multiple sclerosis	1.39e-05	0.000224	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—CCL2—multiple sclerosis	1.36e-05	0.00022	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CXCL10—multiple sclerosis	1.36e-05	0.000219	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—CCL2—multiple sclerosis	1.36e-05	0.000219	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CXCL10—multiple sclerosis	1.35e-05	0.000218	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—POMC—multiple sclerosis	1.35e-05	0.000218	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—SPP1—multiple sclerosis	1.33e-05	0.000216	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—POMC—multiple sclerosis	1.32e-05	0.000214	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CNR1—multiple sclerosis	1.32e-05	0.000214	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—POMC—multiple sclerosis	1.32e-05	0.000214	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—POMC—multiple sclerosis	1.32e-05	0.000213	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—POMC—multiple sclerosis	1.31e-05	0.000212	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CNR1—multiple sclerosis	1.3e-05	0.000211	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—POMC—multiple sclerosis	1.3e-05	0.00021	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CNR1—multiple sclerosis	1.3e-05	0.00021	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—CCR5—multiple sclerosis	1.3e-05	0.00021	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CNR1—multiple sclerosis	1.3e-05	0.000209	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—APOE—multiple sclerosis	1.29e-05	0.000209	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CNR1—multiple sclerosis	1.29e-05	0.000209	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—IL2RA—multiple sclerosis	1.28e-05	0.000207	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CNR1—multiple sclerosis	1.28e-05	0.000207	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—IL2—multiple sclerosis	1.27e-05	0.000205	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—TYK2—multiple sclerosis	1.24e-05	0.0002	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—TYK2—multiple sclerosis	1.23e-05	0.000199	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—POMC—multiple sclerosis	1.22e-05	0.000198	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—POMC—multiple sclerosis	1.2e-05	0.000195	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—POMC—multiple sclerosis	1.2e-05	0.000194	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—POMC—multiple sclerosis	1.2e-05	0.000193	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—CCL2—multiple sclerosis	1.2e-05	0.000193	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—POMC—multiple sclerosis	1.19e-05	0.000193	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CXCL10—multiple sclerosis	1.19e-05	0.000193	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CD86—multiple sclerosis	1.19e-05	0.000192	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—POMC—multiple sclerosis	1.18e-05	0.000191	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—APOE—multiple sclerosis	1.18e-05	0.000191	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CD86—multiple sclerosis	1.18e-05	0.000191	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—CCL2—multiple sclerosis	1.18e-05	0.00019	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—CCL2—multiple sclerosis	1.17e-05	0.00019	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CXCL10—multiple sclerosis	1.17e-05	0.00019	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—CCL2—multiple sclerosis	1.17e-05	0.000189	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CXCL10—multiple sclerosis	1.17e-05	0.000189	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—CD80—multiple sclerosis	1.17e-05	0.000189	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CCL5—multiple sclerosis	1.17e-05	0.000189	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—CCL2—multiple sclerosis	1.17e-05	0.000189	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CXCL10—multiple sclerosis	1.17e-05	0.000189	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CXCL10—multiple sclerosis	1.16e-05	0.000188	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CCL5—multiple sclerosis	1.16e-05	0.000188	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—CCL2—multiple sclerosis	1.16e-05	0.000187	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CXCL10—multiple sclerosis	1.15e-05	0.000186	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—IL2—multiple sclerosis	1.13e-05	0.000183	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—IL2—multiple sclerosis	1.13e-05	0.000182	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—POMC—multiple sclerosis	1.11e-05	0.00018	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—CCL2—multiple sclerosis	1.09e-05	0.000176	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—TYK2—multiple sclerosis	1.09e-05	0.000176	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—SPP1—multiple sclerosis	1.08e-05	0.000175	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—SPP1—multiple sclerosis	1.08e-05	0.000174	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—TYK2—multiple sclerosis	1.07e-05	0.000173	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—CD80—multiple sclerosis	1.07e-05	0.000173	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—TYK2—multiple sclerosis	1.07e-05	0.000172	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—MAPK1—multiple sclerosis	1.06e-05	0.000172	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—TYK2—multiple sclerosis	1.06e-05	0.000172	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—TYK2—multiple sclerosis	1.06e-05	0.000171	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CCR5—multiple sclerosis	1.05e-05	0.00017	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—TYK2—multiple sclerosis	1.05e-05	0.00017	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CCR5—multiple sclerosis	1.05e-05	0.000169	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CD86—multiple sclerosis	1.04e-05	0.000168	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—IL2RA—multiple sclerosis	1.04e-05	0.000168	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—IL2RA—multiple sclerosis	1.03e-05	0.000167	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—IL2—multiple sclerosis	1.03e-05	0.000166	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CCL5—multiple sclerosis	1.03e-05	0.000166	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CD86—multiple sclerosis	1.03e-05	0.000166	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—IL2—multiple sclerosis	1.02e-05	0.000166	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CD86—multiple sclerosis	1.02e-05	0.000165	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CD86—multiple sclerosis	1.02e-05	0.000165	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CD86—multiple sclerosis	1.02e-05	0.000164	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—POMC—multiple sclerosis	1.01e-05	0.000164	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CCL5—multiple sclerosis	1.01e-05	0.000163	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CCL5—multiple sclerosis	1.01e-05	0.000163	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CD86—multiple sclerosis	1.01e-05	0.000163	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CCL5—multiple sclerosis	1e-05	0.000162	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CCL5—multiple sclerosis	1e-05	0.000162	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—IL2—multiple sclerosis	9.95e-06	0.000161	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—CCL2—multiple sclerosis	9.93e-06	0.00016	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CCL5—multiple sclerosis	9.91e-06	0.00016	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—TYK2—multiple sclerosis	9.87e-06	0.00016	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—APOE—multiple sclerosis	9.81e-06	0.000159	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—IL2—multiple sclerosis	9.79e-06	0.000158	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—IL2—multiple sclerosis	9.77e-06	0.000158	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—IL2—multiple sclerosis	9.74e-06	0.000158	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—MAPK1—multiple sclerosis	9.71e-06	0.000157	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—IL2—multiple sclerosis	9.71e-06	0.000157	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—IL2—multiple sclerosis	9.62e-06	0.000155	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—APOE—multiple sclerosis	9.58e-06	0.000155	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—APOE—multiple sclerosis	9.53e-06	0.000154	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—SPP1—multiple sclerosis	9.5e-06	0.000154	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—SPP1—multiple sclerosis	9.35e-06	0.000151	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—SPP1—multiple sclerosis	9.33e-06	0.000151	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—SPP1—multiple sclerosis	9.3e-06	0.00015	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—SPP1—multiple sclerosis	9.27e-06	0.00015	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CCR5—multiple sclerosis	9.24e-06	0.000149	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—SPP1—multiple sclerosis	9.18e-06	0.000148	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IL2RA—multiple sclerosis	9.11e-06	0.000147	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CCR5—multiple sclerosis	9.09e-06	0.000147	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CCR5—multiple sclerosis	9.07e-06	0.000147	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CCR5—multiple sclerosis	9.05e-06	0.000146	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—IL2—multiple sclerosis	9.04e-06	0.000146	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CCR5—multiple sclerosis	9.02e-06	0.000146	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—TYK2—multiple sclerosis	9.01e-06	0.000146	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IL2RA—multiple sclerosis	8.96e-06	0.000145	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IL2RA—multiple sclerosis	8.94e-06	0.000145	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CCR5—multiple sclerosis	8.93e-06	0.000144	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IL2RA—multiple sclerosis	8.91e-06	0.000144	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—IL2—multiple sclerosis	8.89e-06	0.000144	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IL2RA—multiple sclerosis	8.89e-06	0.000144	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—IL2—multiple sclerosis	8.88e-06	0.000143	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—IL2—multiple sclerosis	8.85e-06	0.000143	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—IL2—multiple sclerosis	8.82e-06	0.000143	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IL2RA—multiple sclerosis	8.8e-06	0.000142	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—IL2—multiple sclerosis	8.73e-06	0.000141	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CD80—multiple sclerosis	8.66e-06	0.00014	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CD80—multiple sclerosis	8.61e-06	0.000139	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—POMC—multiple sclerosis	8.43e-06	0.000136	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—APOE—multiple sclerosis	8.41e-06	0.000136	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—APOE—multiple sclerosis	8.27e-06	0.000134	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—APOE—multiple sclerosis	8.26e-06	0.000133	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—APOE—multiple sclerosis	8.23e-06	0.000133	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—POMC—multiple sclerosis	8.23e-06	0.000133	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—IL2—multiple sclerosis	8.22e-06	0.000133	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—APOE—multiple sclerosis	8.2e-06	0.000133	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—POMC—multiple sclerosis	8.18e-06	0.000132	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—IL6—multiple sclerosis	8.18e-06	0.000132	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—APOE—multiple sclerosis	8.12e-06	0.000131	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CCL2—multiple sclerosis	8.05e-06	0.00013	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CCL2—multiple sclerosis	8.01e-06	0.000129	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—MAPK1—multiple sclerosis	7.88e-06	0.000127	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—MAPK1—multiple sclerosis	7.84e-06	0.000127	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—MMP9—multiple sclerosis	7.78e-06	0.000126	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—ALB—multiple sclerosis	7.68e-06	0.000124	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CD80—multiple sclerosis	7.6e-06	0.000123	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—IL2—multiple sclerosis	7.5e-06	0.000121	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CD80—multiple sclerosis	7.48e-06	0.000121	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CD80—multiple sclerosis	7.46e-06	0.000121	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—IL6—multiple sclerosis	7.46e-06	0.000121	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CD80—multiple sclerosis	7.44e-06	0.00012	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CD80—multiple sclerosis	7.42e-06	0.00012	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CD80—multiple sclerosis	7.34e-06	0.000119	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—TYK2—multiple sclerosis	7.31e-06	0.000118	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—TYK2—multiple sclerosis	7.27e-06	0.000118	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—POMC—multiple sclerosis	7.22e-06	0.000117	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—POMC—multiple sclerosis	7.11e-06	0.000115	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—MMP9—multiple sclerosis	7.1e-06	0.000115	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—POMC—multiple sclerosis	7.09e-06	0.000115	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—POMC—multiple sclerosis	7.07e-06	0.000114	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CCL2—multiple sclerosis	7.07e-06	0.000114	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—POMC—multiple sclerosis	7.05e-06	0.000114	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—POMC—multiple sclerosis	6.98e-06	0.000113	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CCL2—multiple sclerosis	6.95e-06	0.000112	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CCL2—multiple sclerosis	6.94e-06	0.000112	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CCL2—multiple sclerosis	6.92e-06	0.000112	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—MAPK1—multiple sclerosis	6.91e-06	0.000112	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—STAT3—multiple sclerosis	6.91e-06	0.000112	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CCL2—multiple sclerosis	6.89e-06	0.000111	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CCL2—multiple sclerosis	6.83e-06	0.00011	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—MAPK1—multiple sclerosis	6.8e-06	0.00011	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—MAPK1—multiple sclerosis	6.79e-06	0.00011	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—MAPK1—multiple sclerosis	6.77e-06	0.000109	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—MAPK1—multiple sclerosis	6.75e-06	0.000109	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—MAPK1—multiple sclerosis	6.68e-06	0.000108	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—MYC—multiple sclerosis	6.42e-06	0.000104	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—TYK2—multiple sclerosis	6.42e-06	0.000104	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—TGFB1—multiple sclerosis	6.41e-06	0.000104	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—TYK2—multiple sclerosis	6.31e-06	0.000102	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—STAT3—multiple sclerosis	6.31e-06	0.000102	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—TYK2—multiple sclerosis	6.3e-06	0.000102	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—MAPK1—multiple sclerosis	6.29e-06	0.000102	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—TYK2—multiple sclerosis	6.28e-06	0.000102	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—TYK2—multiple sclerosis	6.26e-06	0.000101	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—TYK2—multiple sclerosis	6.2e-06	0.0001	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—IL2—multiple sclerosis	6.08e-06	9.83e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—IL6—multiple sclerosis	6.05e-06	9.78e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—IL2—multiple sclerosis	6.05e-06	9.78e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—IL6—multiple sclerosis	6.02e-06	9.73e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—MYC—multiple sclerosis	5.86e-06	9.48e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—TGFB1—multiple sclerosis	5.85e-06	9.46e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MMP9—multiple sclerosis	5.76e-06	9.31e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—MAPK1—multiple sclerosis	5.74e-06	9.28e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MMP9—multiple sclerosis	5.73e-06	9.26e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IL2—multiple sclerosis	5.34e-06	8.63e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—IL6—multiple sclerosis	5.31e-06	8.59e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IL2—multiple sclerosis	5.25e-06	8.5e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IL2—multiple sclerosis	5.24e-06	8.48e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—IL6—multiple sclerosis	5.23e-06	8.45e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IL2—multiple sclerosis	5.23e-06	8.45e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—IL6—multiple sclerosis	5.22e-06	8.43e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IL2—multiple sclerosis	5.21e-06	8.42e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—IL6—multiple sclerosis	5.2e-06	8.41e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—IL6—multiple sclerosis	5.18e-06	8.38e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IL2—multiple sclerosis	5.16e-06	8.34e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—IL6—multiple sclerosis	5.13e-06	8.3e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—STAT3—multiple sclerosis	5.12e-06	8.27e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—STAT3—multiple sclerosis	5.09e-06	8.23e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MMP9—multiple sclerosis	5.05e-06	8.17e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MMP9—multiple sclerosis	4.97e-06	8.04e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MMP9—multiple sclerosis	4.96e-06	8.02e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MMP9—multiple sclerosis	4.95e-06	8e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MMP9—multiple sclerosis	4.93e-06	7.97e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MMP9—multiple sclerosis	4.88e-06	7.89e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—IL6—multiple sclerosis	4.83e-06	7.81e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MYC—multiple sclerosis	4.76e-06	7.69e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—TGFB1—multiple sclerosis	4.74e-06	7.67e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MYC—multiple sclerosis	4.73e-06	7.65e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—TGFB1—multiple sclerosis	4.72e-06	7.63e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MAPK1—multiple sclerosis	4.65e-06	7.52e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MAPK1—multiple sclerosis	4.63e-06	7.48e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—STAT3—multiple sclerosis	4.49e-06	7.27e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—STAT3—multiple sclerosis	4.42e-06	7.15e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—STAT3—multiple sclerosis	4.41e-06	7.13e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—IL6—multiple sclerosis	4.41e-06	7.13e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—STAT3—multiple sclerosis	4.4e-06	7.11e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—STAT3—multiple sclerosis	4.38e-06	7.09e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—STAT3—multiple sclerosis	4.34e-06	7.02e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MYC—multiple sclerosis	4.18e-06	6.75e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—TGFB1—multiple sclerosis	4.17e-06	6.73e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MYC—multiple sclerosis	4.11e-06	6.64e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MYC—multiple sclerosis	4.1e-06	6.63e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—TGFB1—multiple sclerosis	4.1e-06	6.63e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—TGFB1—multiple sclerosis	4.09e-06	6.61e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MYC—multiple sclerosis	4.09e-06	6.61e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MAPK1—multiple sclerosis	4.08e-06	6.6e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—TGFB1—multiple sclerosis	4.08e-06	6.59e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MYC—multiple sclerosis	4.07e-06	6.59e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—TGFB1—multiple sclerosis	4.06e-06	6.57e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MYC—multiple sclerosis	4.03e-06	6.52e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—TGFB1—multiple sclerosis	4.02e-06	6.51e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MAPK1—multiple sclerosis	4.02e-06	6.5e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MAPK1—multiple sclerosis	4.01e-06	6.48e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MAPK1—multiple sclerosis	4e-06	6.46e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MAPK1—multiple sclerosis	3.99e-06	6.44e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MAPK1—multiple sclerosis	3.95e-06	6.38e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—IL6—multiple sclerosis	3.57e-06	5.78e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—IL6—multiple sclerosis	3.56e-06	5.75e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IL6—multiple sclerosis	3.14e-06	5.07e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IL6—multiple sclerosis	3.09e-06	4.99e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IL6—multiple sclerosis	3.08e-06	4.98e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IL6—multiple sclerosis	3.07e-06	4.97e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IL6—multiple sclerosis	3.06e-06	4.95e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IL6—multiple sclerosis	3.03e-06	4.9e-05	CbGpPWpGaD
